Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:1300-1311

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranger, S.
Right arrow Articles by Nattel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ranger, S.
Right arrow Articles by Nattel, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Circulation. 1995;92:1300-1311.)
© 1995 American Heart Association, Inc.


Articles

Determinants and Mechanisms of Flecainide-Induced Promotion of Ventricular Tachycardia in Anesthetized Dogs

Suzanne Ranger, BSC; Stanley Nattel, MD

From the Department of Medicine (S.N.), Montreal Heart Institute and the University of Montreal, and Department of Pharmacology and Therapeutics (S.R., S.N.), McGill University, Montreal, Canada.

Background Class IC antiarrhythmic agents such as flecainide are known to have potentially significant ventricular proarrhythmic actions, but the underlying mechanisms are incompletely understood. While some studies have reported proarrhythmia in both healthy dogs and dogs that previously have had a myocardial infarction (MI), there are no published, controlled studies comparing proarrhythmia in healthy dogs vs in dogs with MI. In addition, the concentration dependence of proarrhythmia is unknown and the electrophysiological changes associated with proarrhythmia are not well established.

Methods We administered successive loading and maintenance infusions of flecainide until ventricular tachyarrhythmia or death occurred in 13 healthy dogs and 19 dogs with 72-hour-old MIs (MI dogs). Ventricular proarrhythmia, defined as reproducible ventricular tachycardia absent under control conditions and occurring in the presence of flecainide, was observed in 4 of 13 healthy dogs (31%) and 15 of 19 MI dogs (79%, P=.02), and drug-induced spontaneous ventricular tachycardia occurred in 8 of 19 MI dogs but in no healthy dogs (P=.007). Activation data at the time of proarrhythmia were available for 11 MI dogs and provided evidence for reentry in 9, with a complete epicardial reentry circuit identified in 4 dogs and a partial circuit in 5. While flecainide slowed ventricular conduction in both the longitudinal and transverse directions, there were no significant differences between overall drug-induced conduction changes in MI dogs compared with healthy dogs. However, in 7 MI dogs for whom activation data were available during ventricular pacing at concentrations comparable to those causing proarrhythmia, flecainide induced a new arc of block in 6 of 7, whereas an arc of block was never observed in the absence of proarrhythmia. Conduction block was induced transverse to fiber orientation in a rate-dependent fashion and was caused by a regionally-specific effect of the drug. No differences were noted between refractory periods proximal and distal to the site of block.

Conclusions Prior MI strongly predisposes dogs to flecainide proarrhythmia, which occurs in the majority of such dogs in a concentration-related way. In most cases, activation data suggest that anisotropic reentry around a localized arc of rate-dependent transverse conduction block underlies proarrhythmia. These results provide insights into the conditions and mechanisms underlying the ability of flecainide to promote the occurrence of ventricular tachycardia.


Key Words: myocardial infarction • antiarrhythmia agents • sodium • arrhythmia • death, sudden




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh
Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation
Physiol Rev, April 1, 2007; 87(2): 425 - 456.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Fukuda, S. S. Davies, T. Nakajima, B.-H. Ong, S. Kupershmidt, J. Fessel, V. Amarnath, M. E. Anderson, P. A. Boyden, P. C. Viswanathan, et al.
Oxidative Mediated Lipid Peroxidation Recapitulates Proarrhythmic Effects on Cardiac Sodium Channels
Circ. Res., December 9, 2005; 97(12): 1262 - 1269.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Tachibana, M. Yamaki, I. Kubota, T. Watanabe, S. Yamauchi, and H. Tomoike
Intracoronary Flecainide Induces ST Alternans and Reentrant Arrhythmia on Intact Canine Heart : A Role of 4-Aminopyridine–Sensitive Current
Circulation, March 30, 1999; 99(12): 1637 - 1643.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Nattel
Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs
Cardiovasc Res, March 1, 1998; 37(3): 567 - 577.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. T. Cragun, S. B. Johnson, and D. L. Packer
ß-Adrenergic Augmentation of Flecainide-Induced Conduction Slowing in Canine Purkinje Fibers
Circulation, October 21, 1997; 96(8): 2701 - 2708.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Koura, M. Hara, S. Takeuchi, K. Ota, Y. Okada, S. Miyoshi, A. Watanabe, K. Shiraiwa, H. Mitamura, I. Kodama, et al.
Anisotropic Conduction Properties in Canine Atria Analyzed by High-Resolution Optical Mapping: Preferential Direction of Conduction Block Changes From Longitudinal to Transverse With Increasing Age
Circulation, April 30, 2002; 105(17): 2092 - 2098.
[Abstract] [Full Text] [PDF]